SCHEMBL25625877

SCHEMBL25625877

Fc1ccc2c(ccc3c4ccncc4ccc23)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHUK O15111 1/20 0.46
ACHE P22303 1/20 0.43
CYP11B2 P19099 3/20 0.43
CYP19A1 P11511 2/20 0.43
CYP11B1 P15538 2/20 0.43
IMPDH2 P12268 3/20 0.42
MAPT P10636 2/20 0.41
CYP1A2 P05177 2/20 0.40
LMNA P02545 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPKAPK2 P49137 1/20 0.40
CLK1 P49759 1/20 0.40
CLK2 P49760 1/20 0.40
DYRK1A Q13627 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
DYRK1B Q9Y463 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23557738 0.98 CHUK (0.47) CHUKACHECYP11B2CYP19A1CYP11B1
SCHEMBL22490163 0.85 HIPK2 (0.53) CHUKACHEMAPTCYP1A2KDM4E
SCHEMBL12405217 0.81 CYP1A2 (0.55) MAPTCYP1A2LMNAKDM4EALDH1A1
SCHEMBL12277510 0.81 CYP1A2 (0.55) MAPTCYP1A2LMNAKDM4EALDH1A1
SCHEMBL12260024 0.81 CYP1A2 (0.55) MAPTCYP1A2LMNAKDM4EALDH1A1
SCHEMBL11144191 0.79 PRKCZ (0.50) CHUKACHECYP11B2CYP19A1MAPT
SCHEMBL30387605 0.79 MAPT (0.53) CHUKACHECYP11B2CYP19A1IMPDH2
SCHEMBL29875363 0.79 PRKCZ (0.50) CHUKACHECYP11B2CYP19A1MAPT
SCHEMBL1551786 0.79 MAPT (0.53) CHUKACHECYP11B2CYP19A1IMPDH2
SCHEMBL12532558 0.79 IMPDH2 (0.50) CYP11B1IMPDH2CYP1A2LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192719-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CANON KABUSHIKI KAISHA (JP) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192719-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT OR10J3, CRY1, RPS19 CHUK 3067/4885ACHE 3404/4885CYP11B2 677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.